Bioorganic & Medicinal Chemistry Letters 2010-02-01

Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.

Gunther Zischinsky, Roland Stragies, Marco Schaudt, Jochen R Pfeifer, Christoph Gibson, Elsa Locardi, Dirk Scharn, Uwe Richter, Holger Kalkhof, Klaus Dinkel, Karsten Schnatbaum

Index: Bioorg. Med. Chem. Lett. 20(3) , 1229-32, (2010)

Full Text: HTML

Abstract

Efforts to find new bradykinin B(1) receptor antagonists identified 2-aminobenzimidazole as a novel core. Subsequent transformation into five-membered diaminoheterocycle derivatives and their synthesis and SAR is described. This resulted in compounds with low nanomolar activity.Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Related Compounds

  • 2-Aminobenzimidazo...

Related Articles:

Aggregation of 2-aminobenzimidazole--a combined experimental and theoretical investigation.

2011-06-20

[ChemPhysChem 12(9) , 1747-55, (2011)]

Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.

2009-08-01

[Bioorg. Med. Chem. Lett. 19(15) , 4380-4, (2009)]

Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C.

2010-03-19

[ACS Chem. Biol. 5 , 287-299, (2010)]

Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

2009-07-01

[Bioorg. Med. Chem. Lett. 19(13) , 3568-72, (2009)]

Synthesis and QSAR studies of novel 1-substituted-2-aminobenzimidazoles derivatives.

2006-09-01

[Eur. J. Med. Chem. 41(9) , 1080-3, (2006)]

More Articles...